This is a routine Form 144 filing by an officer selling shares acquired through equity compensation. No material change in company outlook is implied. Monitor for any subsequent Form 4 filings to confirm execution and assess if the selling pattern broadens to other insiders.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Oct 23 $439.95entry
- T+1 · 22d ago −1.96%α −2.67% · $431.32
- T+5 · 18d ago −4.52%α −3.96% · $420.07
- T+16 · todayOpen
- T+20 · in 3d Pending
- T+60 · in 2mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Elevance Health officer Mark Kaye filed a Form 144 notice of intent to sell 10,584 shares of common stock, with an estimated aggregate market value of approximately $4.66 million based on the filing date. The shares were acquired through restricted stock and performance share grants between October 2022 and October 2026. This is a routine insider sale notice and does not indicate a change in company fundamentals.
Key Facts
- Officer Mark Kaye filed Form 144 to sell 10,584 shares of Elevance Health common stock.
- Estimated aggregate market value of the proposed sale is approximately $4.66 million.
- Shares were acquired through restricted stock and performance share grants from October 2022 through October 2026.
- The sale is planned to occur on or after October 22, 2026, on the NYSE.
Financial Impact
Proposed sale of 10,584 shares valued at ~$4.66 million, a small fraction of the company's market cap.
Risk Factors
- Insider selling could accelerate if the stock price weakens or if other officers follow suit.
- Form 144 is an intent to sell; the actual sale may not occur.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-010359 |
| Document: 0001950047-26-010359-index.html | 0001950047-26-010359 |
| Document: 0001950047-26-010359.txt | 0001950047-26-010359 |
Track record
19 reports on ELV
1 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +3.93% at T+5 after the Aug 27, 2026 report. 2 of 3 went positive at some point.
Filters
- Nov 10, 20266d ago 8-K Neutral 2/10 Entry $429.48 Now $446.28 +3.91% settles Nov 18
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $425.62 to $429.69 Now $446.28 +4.85% ▲ +0.96% −1.64% vs SPY
- Oct 28, 202619d ago S-3ASR Neutral 3/10 Entry $422.02 to $432.00 Now $446.28 +5.75% ▲ +2.36% +7.09% vs SPY
- Oct 22, 202625d ago 144 Neutral 2/10 Viewing Entry $439.95 to $420.07 Now $446.28 +1.44% ▼ −4.52% −3.96% vs SPY
- Oct 21, 202626d ago 8-K Bullish 7/10 Entry $434.13 to $421.49 Now $446.28 +2.80% ▼ −2.91% −2.47% vs SPY
- Oct 20, 202627d ago Institutional Cluster Neutral 3/10 Entry $434.13 to $421.49 Now $446.28 +2.80% ▼ −2.91% −2.47% vs SPY
- Sep 10, 20269w ago 8-K Neutral 3/10 Entry $416.54 to $414.26 Now $446.28 +7.14% ▼ −0.55% −0.05% vs SPY
- Aug 27, 202611w ago Institutional Cluster Bullish 6/10 Entry $399.11 to $414.78 Now $446.28 +11.82% ▲ +3.93% +3.66% vs SPY
- Aug 20, 202612w ago Court Ruling Neutral 2/10 Entry $400.54 to $394.43 Now $446.28 +11.42% ▼ −1.53% −2.00% vs SPY
- Aug 17, 202613w ago Court Ruling Neutral 1/10 Entry $396.54 to $397.14 Now $446.28 +12.54% ▲ +0.15% +0.35% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers